These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 28946004)

  • 21. Detection of unexpected lupus anticoagulant during preparation of normal pooled plasma (NPP) from healthy volunteers.
    Ghosh K; Shetty S; Mohanty D
    Thromb Haemost; 2000 Sep; 84(3):519-21. PubMed ID: 11019985
    [No Abstract]   [Full Text] [Related]  

  • 22. Mixing test specific cut-off is more sensitive at detecting lupus anticoagulants than index of circulating anticoagulant.
    Moore GW; Culhane AP; Daw CR; Noronha CP; Kumano O
    Thromb Res; 2016 Mar; 139():98-101. PubMed ID: 26916303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lupus anticoagulant assays: questions answered and to be answered.
    Teruya J; West AG; Suell MN
    Arch Pathol Lab Med; 2007 Jun; 131(6):885-9. PubMed ID: 17550315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lupus-anticoagulant testing at NOAC trough levels.
    Ratzinger F; Lang M; Belik S; Jilma-Stohlawetz P; Schmetterer KG; Haslacher H; Perkmann T; Quehenberger P
    Thromb Haemost; 2016 Aug; 116(2):235-40. PubMed ID: 27075441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of the lupus anticoagulant in pregnancy.
    Derksen RH; Out HJ; Blokzijl L; de Groot PG
    Clin Exp Rheumatol; 1992; 10(3):323-4. PubMed ID: 1582083
    [No Abstract]   [Full Text] [Related]  

  • 26. Laboratory identification of lupus anticoagulants.
    Kershaw G; Suresh S; Orellana D; Nguy YM
    Semin Thromb Hemost; 2012 Jun; 38(4):375-84. PubMed ID: 22573409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Normal plasma mixing studies in the laboratory diagnosis of lupus anticoagulant.
    Thom J; Ivey L; Eikelboom J
    J Thromb Haemost; 2003 Dec; 1(12):2689-91. PubMed ID: 14675112
    [No Abstract]   [Full Text] [Related]  

  • 28. Coagulation mixing studies: Utility, algorithmic strategies and limitations for lupus anticoagulant testing or follow up of abnormal coagulation tests.
    Favaloro EJ
    Am J Hematol; 2020 Jan; 95(1):117-128. PubMed ID: 31674066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lupus anticoagulant syndrome: case report.
    Mwanda OW
    East Afr Med J; 1998 Oct; 75(10):619-20. PubMed ID: 10065201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. More on: normal plasma mixing studies in the laboratory diagnosis of lupus anticoagulant.
    Chang S
    J Thromb Haemost; 2004 Aug; 2(8):1480-1. PubMed ID: 15304065
    [No Abstract]   [Full Text] [Related]  

  • 31. Laboratory diagnosis of the lupus anticoagulant.
    Ortel TL
    Curr Rheumatol Rep; 2012 Feb; 14(1):64-70. PubMed ID: 22134845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance of the mixing test in laboratory diagnoses of lupus anticoagulant: the fate of the mixing test in integrated lupus anticoagulant test systems.
    Hong SK; Hwang SM; Kim JE; Kim HK
    Blood Coagul Fibrinolysis; 2012 Dec; 23(8):739-44. PubMed ID: 22964767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Standardization of lupus anticoagulant. The Lupus Anticoagulant Sensitivity Index (LASI).
    Tripodi A; Chantarangkul V; Pengo V
    Lupus; 2012 Jun; 21(7):715-7. PubMed ID: 22635210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lupus anticoagulant: case-based external quality assessment.
    van den Besselaar AM; Devreese KM; de Groot PG; Castel A
    J Clin Pathol; 2009 Aug; 62(8):731-4. PubMed ID: 19638545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lupus Anticoagulant Testing: Activated Partial Thromboplastin Time (APTT) and Silica Clotting Time (SCT).
    Tripodi A; Chantarangkul V
    Methods Mol Biol; 2017; 1646():177-183. PubMed ID: 28804829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in lupus anticoagulant final conclusion through clotting time or Rosner index for mixing test interpretation.
    Depreter B; Devreese KM
    Clin Chem Lab Med; 2016 Sep; 54(9):1511-6. PubMed ID: 26894579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of procoagulant phospholipid interfering in tests for lupus anticoagulant.
    Exner T; Low J
    Thromb Res; 2004; 114(5-6):547-52. PubMed ID: 15507290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interpretation of clot-based lupus anticoagulant assays-Normalizing clotting time against different denominators.
    Ling LQ; Liu CN; Huang XB; Liao J; Jia J; Zhou J
    Int J Lab Hematol; 2022 Aug; 44(4):777-784. PubMed ID: 35297205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical importance of positive test results for lupus anticoagulant and anticardiolipin antibodies.
    Proven A; Bartlett RP; Moder KG; Chang-Miller A; Cardel LK; Heit JA; Homburger HA; Petterson TM; Christianson TJ; Nichols WL
    Mayo Clin Proc; 2004 Apr; 79(4):467-75. PubMed ID: 15065611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Mixing test for prolonged clotting time: clinical availability and problems].
    Uchiba M; Ando Y
    Rinsho Byori; 2009 Oct; 57(10):1004-12. PubMed ID: 19928499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.